All posts tagged Actavis

biopharmaceuticals

Pharmaceuticals firm Novartis denies talk on bid for generic drug maker Actavis

Swiss pharma major Novartis AG (VTX:NOVN) does not intend to pursue a takeover of US drugmaker Actavis Inc (NYSE:ACT), a company spokesperson told Reuters, refuting a previous report by the Wall Street Journal. Earlier this week, the paper cited insiders …

Continue Reading...
Pharmaceutical manufacturing

Actavis says discusses merger with Warner Chilcott

US speciality pharmaceutical company Actavis Inc (NYSE:ACT) said it had engaged in early-stage talks to potentially combine with Irish sector player Warner Chilcott plc (NASDAQ:WCRX). The US firm noted

Generic drugs

Generic drug firm Watson completes acquisition of Actavis

US generic drugs maker Watson Pharmaceuticals Inc (NYSE:WPI) said it had finalised the acquisition of Swiss-Icelandic peer Actavis Group. The parties sealed the definitive agreement in April and received

Euro in crisis

US-based Watson seals a deal to acquire Icelandic generic drugmaker Actavis

US generic drugs maker Watson Pharmaceuticals Inc (NYSE:WPI) has reached a deal to take over Icelandic peer Actavis Group for an initial price of EUR4.25bn (USD5.6bn), plus a

Powered by WordPress